Research ArticleAdult Brain
Gadolinium Retention in the Brain: An MRI Relaxometry Study of Linear and Macrocyclic Gadolinium-Based Contrast Agents in Multiple Sclerosis
Y. Forslin, J. Martola, Å. Bergendal, S. Fredrikson, M.K. Wiberg and T. Granberg
American Journal of Neuroradiology August 2019, 40 (8) 1265-1273; DOI: https://doi.org/10.3174/ajnr.A6112
Y. Forslin
aFrom the Department of Clinical Neuroscience (Y.F., J.M., Å.B., S.F., M.K.W., T.G.), Karolinska Institutet, Stockholm, Sweden
bDepartments of Radiology (Y.F., J.M., M.K.W., T.G.)
J. Martola
aFrom the Department of Clinical Neuroscience (Y.F., J.M., Å.B., S.F., M.K.W., T.G.), Karolinska Institutet, Stockholm, Sweden
bDepartments of Radiology (Y.F., J.M., M.K.W., T.G.)
Å. Bergendal
aFrom the Department of Clinical Neuroscience (Y.F., J.M., Å.B., S.F., M.K.W., T.G.), Karolinska Institutet, Stockholm, Sweden
S. Fredrikson
aFrom the Department of Clinical Neuroscience (Y.F., J.M., Å.B., S.F., M.K.W., T.G.), Karolinska Institutet, Stockholm, Sweden
cNeurology (S.F.), Karolinska University Hospital, Stockholm, Sweden
M.K. Wiberg
aFrom the Department of Clinical Neuroscience (Y.F., J.M., Å.B., S.F., M.K.W., T.G.), Karolinska Institutet, Stockholm, Sweden
bDepartments of Radiology (Y.F., J.M., M.K.W., T.G.)
dDepartment of Medical and Health Sciences (M.K.W.), Division of Radiological Sciences, Linköping University, Linköping, Sweden.
T. Granberg
aFrom the Department of Clinical Neuroscience (Y.F., J.M., Å.B., S.F., M.K.W., T.G.), Karolinska Institutet, Stockholm, Sweden
bDepartments of Radiology (Y.F., J.M., M.K.W., T.G.)

REFERENCES
- 1.↵
- Kanda T,
- Ishii K,
- Kawaguchi H, et al
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- Bjørnerud A,
- Vatnehol SA,
- Larsson C, et al
- 6.↵
- Rossi Espagnet MC,
- Bernardi B,
- Pasquini L, et al
- 7.↵
- Splendiani A,
- Perri M,
- Marsecano C, et al
- 8.↵
- 9.↵
- 10.↵
- 11.↵
- 12.↵
- Rohrer M,
- Bauer H,
- Mintorovitch J, et al
- 13.↵European Medicines Agency. EMA's final opinion confirms restrictions on use of linear gadolinium agents in body scans. 625317Accessed January 29, 2019. July 21, 2017. https://www.ema.europa.eu/en/news/emas-final-opinion-confirms-restrictions-use-linear-gadolinium-agents-body-scans. Accessed January 29, 2019.
- 14.↵US Food and Drug Administration. FDA Drug Safety Communication: FDA warns that gadolinium-based contrast agents (GBCAs) are retained in the body; requires new class warnings. 2017. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-gadolinium-based-contrast-agents-gbcas-are-retained-body. Accessed February 15, 2019.
- 15.↵
- 16.↵
- McDonald RJ
- 17.↵
- Forslin Y,
- Shams S,
- Hashim F, et al
- 18.↵
- Vågberg M,
- Axelsson M,
- Birgander R, et al
- 19.↵
- 20.↵
- Mangeat G,
- Ouellette R,
- Warntjes JBM, et al
- 21.↵
- Vågberg M,
- Lindqvist T,
- Ambarki K, et al
- 22.↵
- Granberg T,
- Uppman M,
- Hashim F, et al
- 23.↵
- 24.↵
- Ashburner J,
- Friston KJ
- 25.↵
- Errante Y,
- Cirimele V,
- Mallio CA, et al
- 26.↵
- Yushkevich PA,
- Piven J,
- Hazlett HC, et al
- 27.↵
- Jenkinson M,
- Beckmann CF,
- Behrens TE, et al
- 28.↵
- Benjamini Y,
- Hochberg Y
- 29.↵
- 30.↵
- Bond KM,
- Brinjikji W,
- Eckel LJ, et al
- 31.↵
- Robert P,
- Lehericy S,
- Grand S, et al
- 32.↵
- 33.↵
- 34.↵
- Chiaravalloti ND,
- DeLuca J
- 35.↵
- 36.↵
- Mallio CA,
- Piervincenzi C,
- Gianolio E, et al
- 37.↵
In this issue
American Journal of Neuroradiology
Vol. 40, Issue 8
1 Aug 2019
Advertisement
Gadolinium Retention in the Brain: An MRI Relaxometry Study of Linear and Macrocyclic Gadolinium-Based Contrast Agents in Multiple Sclerosis
Y. Forslin, J. Martola, Å. Bergendal, S. Fredrikson, M.K. Wiberg, T. Granberg
American Journal of Neuroradiology Aug 2019, 40 (8) 1265-1273; DOI: 10.3174/ajnr.A6112
Gadolinium Retention in the Brain: An MRI Relaxometry Study of Linear and Macrocyclic Gadolinium-Based Contrast Agents in Multiple Sclerosis
Y. Forslin, J. Martola, Å. Bergendal, S. Fredrikson, M.K. Wiberg, T. Granberg
American Journal of Neuroradiology Aug 2019, 40 (8) 1265-1273; DOI: 10.3174/ajnr.A6112
Jump to section
Related Articles
Cited By...
- MR Imaging Signs of Gadolinium Retention Are Not Associated with Long-Term Motor and Cognitive Outcomes in Multiple Sclerosis
- Does Gadolinium Deposition Lead to Metabolite Alteration in the Dentate Nucleus? An MRS Study in Patients with MS
- Safety of Gadolinium-Based Contrast Agents in Patients with Stage 4 and 5 Chronic Kidney Disease: a Radiologists Perspective
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Adult Brain
Patient Safety
Similar Articles
Advertisement